Publication | Closed Access

Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol

9-Week Double-blind TrialPsychiatryMedicinePsychotropic MedicationDepressionSchizophreniaContinuation Risperidone MonotherapyPsychiatric DisorderMental HealthBipolar ManiaPsychotherapyPsychopathologyBipolar Disorder